Marrone Bio Innovations Investor Relations Material
Latest events
Q1 2022
Marrone Bio Innovations
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Marrone Bio Innovations Inc
Access all reports
Marrone Bio Innovations, Inc. develops beneficial bacillus products for crop yield, quality, and performance. The company's products are manufactured from naturally occurring soil bacteria that have been used as microbial pesticides to control pests such as nematodes, insects, and mites. Its products include Regalia, Great Lakes BioSystems' proprietary plant-based bacillus formula for enhancing plant growth and controlling fungal disease; Grandevo, a biopesticide containing three different strains of beneficial bacilli for controlling insect pests and diseases; and Majestene, an insecticide containing various biopesticides to suppress nematode populations.
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States